Trials / Completed
CompletedNCT03426267
Evaluation of Efficacy and Safety of SDN-037
A Randomized, Double-Masked, Parallel Group, Multicenter, Study To Evaluate Efficacy And Safety of SDN -037 Twice Daily Compared With Vehicle For The Treatment Of Inflammation And Pain Associated With Ocular Surgery.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 325 (actual)
- Sponsor
- Sun Pharma Advanced Research Company Limited · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The efficacy and safety of SDN-037 twice daily will be evaluated and compared with vehicle for the treatment of inflammation and pain associated with ocular surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SDN-037 | twice daily |
| DRUG | Placebo | twice daily |
Timeline
- Start date
- 2018-09-28
- Primary completion
- 2020-03-05
- Completion
- 2020-03-05
- First posted
- 2018-02-08
- Last updated
- 2021-05-17
- Results posted
- 2021-05-17
Locations
19 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03426267. Inclusion in this directory is not an endorsement.